Walleye Capital
CRL icon

Walleye Capital’s Charles River Laboratories CRL Stock Holding History

Walleye Capital’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,932
Closed -$333K – 4797
2026
Q1 		$333K Sell
1,932
-249,189
-99% -$46.2M ﹤0.01% 2990
2025
Q4 		$50.1M Buy
251,121
+25,121
+11% +$4.56M 0.15% 63
2025
Q3 		$35.4M Buy
226,000
+221,782
+5,258% +$35.2M 0.13% 109
2025
Q2 		$640K Buy
+4,218
New +$562K ﹤0.01% 2427
2024
Q3 		– Sell
-63,913
Closed -$13.3M – 5383
2024
Q2 		$13.2M Buy
63,913
+63,778
+47,243% +$14.5M 0.02% 593
2024
Q1 		$36.6K Buy
+135
New +$32.2K ﹤0.01% 4772
2023
Q4 		– Sell
-8,561
Closed -$1.68M – 5021
2023
Q3 		$1.68M Buy
+8,561
New +$1.76M ﹤0.01% 1872
2022
Q4 		– Sell
-28,386
Closed -$5.59M – 3257
2022
Q3 		$5.59M Buy
28,386
+11,427
+67% +$2.47M 0.11% 209
2022
Q2 		$3.63M Sell
16,959
-27,364
-62% -$6.69M 0.1% 228
2022
Q1 		$12.6M Buy
44,323
+13,642
+44% +$4.21M 0.34% 51
2021
Q4 		$11.6M Buy
30,681
+29,744
+3,174% +$11.6M 0.36% 52
2021
Q3 		$387K Buy
+937
New +$389K 0.01% 898
2020
Q1 		– Sell
-1,140
Closed -$175K – 1056
2019
Q4 		$175K Buy
1,140
+1,090
+2,180% +$151K 0.01% 1173
2019
Q3 		$7K Hold
50
– – ﹤0.01% 1788
2019
Q2 		$7K Sell
50
-1,342
-96% -$182K ﹤0.01% 1614
2019
Q1 		$202K Buy
+1,392
New +$183K 0.03% 778

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Walleye Capital's CRL Position: Q2 2026 in Review

Walleye Capital sold out of Charles River Laboratories (CRL) in Q2 2026, closing a stake of 1,932 shares — an estimated $333K sold.

Walleye Capital first reported a position in CRL in Q1 2019 and held it in 16 quarters. The position peaked at $50.1M in Q4 2025. 569 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Walleye Capital reported no remaining Charles River Laboratories position as of Q2 2026 after selling out during the quarter.
  • Walleye Capital sold 1,932 Charles River Laboratories shares in Q2 2026, an estimated $333K.
  • Walleye Capital first reported a position in Charles River Laboratories in Q1 2019 and held it in 16 quarters.
  • Walleye Capital's Charles River Laboratories position peaked at $50.1M in Q4 2025.
  • 569 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.